Proto Labs, Inc. carries a market capitalization of 2.03B, placing it among publicly traded companies globally. Its enterprise value stands at 1.81B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.03B |
| Enterprise Value | 1.81B |
Proto Labs, Inc. currently has 23.92M shares outstanding.
| Shares Outstanding | 23.92M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Proto Labs, Inc. trades at a trailing price-to-earnings ratio of 63.82. The price-to-sales ratio is 3.47, and the price-to-book ratio stands at 2.82.
| PE Ratio | 63.82 |
| PS Ratio | 3.47 |
| PB Ratio | 2.82 |
| P/TBV Ratio | 4.86 |
| P/FCF Ratio | 19.71 |
| P/OCF Ratio | 24.77 |
On an enterprise value basis, Proto Labs, Inc. trades at an EV/EBITDA multiple of 24.52 and an EV/FCF ratio of 18.03. The EV/Sales ratio of 3.23 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 44.05 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.23 |
| EV / EBITDA | 24.52 |
| EV / EBIT | 44.05 |
| EV / FCF | 18.03 |
Proto Labs, Inc. maintains a current ratio of 3.64, meaning it holds 3.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.64 |
| Quick Ratio | 3.27 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 0.03 |
| Interest Coverage | N/A |
Proto Labs, Inc. posts a return on equity of 4.49 and a return on invested capital of 4.36.
| Return on Equity (ROE) | 4.49 |
| Return on Assets (ROA) | 3.97 |
| Return on Invested Capital (ROIC) | 4.36 |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 21.41 |
Over the trailing twelve months, Proto Labs, Inc. has paid 11.85M in income taxes, reflecting an effective tax rate of 27.99.
| Income Tax | 11.85M |
| Effective Tax Rate | 27.99 |
Proto Labs, Inc.'s stock has gained approximately 76.24561% over the past 52 weeks. The 50-day moving average sits at 80.01, while the 200-day moving average is 63.99.
| Beta (5Y) | N/A |
| 52-Week Price Change | 76.24561% |
| 50-Day Moving Average | 80.01 |
| 200-Day Moving Average | 63.99 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Proto Labs, Inc. generated 560.54M in revenue and converted that into 30.48M in net income, yielding earnings per share of 1.26. EBITDA reached 73.78M, while operating income came in at 41.07M.
| Revenue | 560.54M |
| Gross Profit | 254.60M |
| Operating Income | 41.07M |
| Pretax Income | 42.32M |
| Net Income | 30.48M |
| EBITDA | 73.78M |
| EBIT | 41.07M |
| Earnings Per Share (EPS) | 1.26 |
Proto Labs, Inc. holds 142.78M in cash and equivalents against 2.24M in total debt, resulting in a net debt position of -127.92M. Total book value stands at 691.73M, with working capital of 193.04M providing operational flexibility.
| Cash & Cash Equivalents | 142.78M |
| Total Debt | 2.24M |
| Net Debt | -127.92M |
| Equity (Book Value) | 691.73M |
| Book Value Per Share | 28.92 |
| Working Capital | 193.04M |
Proto Labs, Inc. produced 78.52M in operating cash flow over the past twelve months. After subtracting -21.85M in capital expenditures, free cash flow totaled 56.66M - equivalent to 2.37 per share.
| Operating Cash Flow | 78.52M |
| Capital Expenditures | -21.85M |
| Free Cash Flow | 56.66M |
| FCF Per Share | 2.37 |
Proto Labs, Inc. operates with a gross margin of 45.42, reflecting its pricing power and cost economics. The operating margin of 7.33 and net profit margin of 5.44 provide insight into operational efficiency.
| Gross Margin | 45.42 |
| Operating Margin | 7.33 |
| Pretax Margin | 7.55 |
| Profit Margin | 5.44 |
| EBITDA Margin | 13.16 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.98 |
| FCF Yield | 5.07 |
Proto Labs, Inc. posts an Altman Z-Score of 14.31, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 14.31 |